ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Silverback Therapeutics Inc

Silverback Therapeutics Inc (SBTX)

5.87
0.00
(0.00%)
Closed January 01 4:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.87
Bid
2.37
Ask
6.15
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
5.87
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
95,997,000
Dividend Yield
-
PE Ratio
-18.63
Earnings Per Share (EPS)
-0.57
Revenue
30k
Net Profit
-54.37M

About Silverback Therapeutics Inc

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

SBTX Latest News

ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

Data to be Presented in Five Poster Presentations at the 2023 American Academy of Allergy, Asthma and Immunology Annual Meeting Data Support New Drug Application for neffy®, Currently Under Review...

ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

Data from Pivotal Clinical Trials to be Presented in Five Poster Presentations at the 2022 American College of Allergy, Asthma and Immunology Annual Scientific Meeting Data Support New Drug...

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S., if Approved neffy® NDA Currently Under...

Silverback Therapeutics' Nasal Spray for Allergic Reactions Gets FDA Review Approval

By Sabela Ojea Silverback Therapeutics Inc. said Friday that the U.S. Food and Drug Administration has accepted for review its new drug application for Neffy, an emergency nasal spray to treat...

Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis

neffy has potential to be the first non-injectable medicine indicated to treat allergic reactions (type I) including anaphylaxis in the U.S., if approved Silverback Therapeutics, Inc. (Nasdaq:...

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

Transaction to support potential commercialization of neffy™, ARS’s needle-free epinephrine nasal spray Well-funded with at least three years of operating runway expected Companies to host...

Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue...

Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SBTX - Frequently Asked Questions (FAQ)

What is the current Silverback Therapeutics share price?
The current share price of Silverback Therapeutics is $ 5.87
How many Silverback Therapeutics shares are in issue?
Silverback Therapeutics has 95,997,000 shares in issue
What is the market cap of Silverback Therapeutics?
The market capitalisation of Silverback Therapeutics is USD 563.5M
What is the 1 year trading range for Silverback Therapeutics share price?
Silverback Therapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Silverback Therapeutics?
The price to earnings ratio of Silverback Therapeutics is -18.63
What is the cash to sales ratio of Silverback Therapeutics?
The cash to sales ratio of Silverback Therapeutics is 35.17k
What is the reporting currency for Silverback Therapeutics?
Silverback Therapeutics reports financial results in USD
What is the latest annual turnover for Silverback Therapeutics?
The latest annual turnover of Silverback Therapeutics is USD 30k
What is the latest annual profit for Silverback Therapeutics?
The latest annual profit of Silverback Therapeutics is USD -54.37M
What is the registered address of Silverback Therapeutics?
The registered address for Silverback Therapeutics is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Silverback Therapeutics website address?
The website address for Silverback Therapeutics is ars-pharma.com
Which industry sector does Silverback Therapeutics operate in?
Silverback Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDMDBaird Medical Investment Holdings Ltd
$ 7.6699
(630.47%)
89.74M
APMAptorum Group Ltd
$ 2.799
(106.57%)
116.74M
COEPCoeptis Therapeutics Holdings Inc
$ 5.44
(75.48%)
5.08M
VRMEVerifyMe Inc
$ 1.332
(68.63%)
94.04M
VEEETwin Vee PowerCats Company
$ 0.55
(53.59%)
5.62M
WATTEnergous Corporation
$ 1.00
(-62.26%)
29.33M
SGMOSangamo Therapeutics Inc
$ 1.02
(-56.41%)
44.56M
INTZIntrusion Inc
$ 3.07
(-45.95%)
15.07M
KZIAKazia Therapeutics Ltd
$ 1.78
(-42.58%)
708.99k
TOIIWOncology Institute Inc
$ 0.0052
(-42.22%)
366.02k
SVMHSRIVARU Holding Ltd
$ 0.0423
(26.65%)
794.74M
XTIAXTI Aerospace Inc
$ 0.0422
(6.84%)
446.31M
EYENEyenovia Inc
$ 0.1474
(30.10%)
412.83M
CRKNCrown Electrokinetics Corporation
$ 0.146899
(5.91%)
402.05M
ONCOOnconetix Inc
$ 0.6479
(48.26%)
270.47M

Discussion

View Full Feed
TightCoil TightCoil 5 minutes ago
Why are they smiling? Are they happy about something? What?
FNMA
StayHumble StayHumble 5 minutes ago
💹GreensNaturalFoods💹doubles $HCWC💹Revenue $72Million+💹💹 @healthiercmc
https://www.healthiercmc.com/news/20221017-greens-natural-foods

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168
HCWC
ShawnP123 ShawnP123 5 minutes ago
Since Microsoft is Nvidia's biggest customer, this article should be an interesting read. It's not for investors who don't want to read potentially negative news.
https://www.yahoo.com/finance/news/microsoft-ceo-satya-nadella-just-143000753.html
NVDA
HenryB3 HenryB3 5 minutes ago
New year, new Kool aide. What flavor would you like? Grape, fruit punch, orange, and the new lemon lime? Do not forget the tax. Pay the man,Mikah wins out. But don't worry, pipeline is locked and loaded with 10% of the market locked in. Lol. I have a bridge to sell you too.
ELTP
DruidJungle53 DruidJungle53 6 minutes ago
Sorry buddy...that reply was not meant for you. It was meant for abazaba375
SFIO
Pnypnchr Pnypnchr 6 minutes ago
Hell yeah I see everyone is ready for it, especially Unreal Mckoy. Whether it happens or not, nobody leaves until she leaves.
StayHumble StayHumble 7 minutes ago
💹 💹wow Jury Trial Incoming huzzah💹 💹 💹 💹 💹
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
HCMC
Humbert Humbert 8 minutes ago
Very bright year ahead for BNCM
BNCM
williamssc williamssc 9 minutes ago
Agree, I think this is a green light for more institutions to jump in.
AVXL
StayHumble StayHumble 10 minutes ago
💹 MASSIVE MOASS incoming Shortly 💹Blast Off Incoming💹wow https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/trades

"foosball matters"
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
HMBL
gitreal gitreal 11 minutes ago
you have to admit , NBRI and Jared Lazerson sure look like the real deal....😎

Nope. Looks like a blatant pump & dump. Anybody with a lick of common sense can see that.
NBRI
iamthe walrus iamthe walrus 11 minutes ago
Samsung Electronics, LG, SK and Hyundai...Coretec through its share agreement with Core Optics is partnered with all of these large Companies who make up 40% of the GDP in Korea . SK Hynix and LG Innotek are part of a large group of LG and SK companies . Point is that as Korea has had a down market
CRTG
TheDane TheDane 11 minutes ago
$430s tomorrow.
TSLA
weedtrader420 weedtrader420 12 minutes ago
RUN-PETER PIPER XRP $5 TARGET
XRPUSD
XMaster2023 XMaster2023 14 minutes ago
HyGro funny how you are defending Merck. Could it be that you work for them? Are you also saying Merck has access to blind trial data? If so your full of poop.
NWBO
Zorax Zorax 14 minutes ago
Oz can go pound sand. Can't wait for the confirmation hearings when the Dems can expose him and the rest of the junk science and junk economics morons for the charlatans they are.

We can expose all those clowns for the frauds they are all day, but does congress on our side actually ha
janice shell janice shell 14 minutes ago
I see what you mean, though... She seems to have been a sort of Africa enthusiast. Pilot, hunter, conservationist.
trumptard trumptard 16 minutes ago
From journal website: in press = ready for publication, date of journal not available. Corrections complete.
Long, for a very long time.
AVXL
Moonboy1 Moonboy1 17 minutes ago
Is that before or after the reverse split?
TNXP
StayHumble StayHumble 17 minutes ago
"I ShortNaked🔥24/7" tops the list per X MorganStanleyEmployee🔥🔥🔥 wow
“Gaming Wall Street”- HBO Documentary

Ex Morgan Stanley employee explains the situation about shorting and naked shorting perfectly!
Again, this is a MUST WATCH video
xodcode xodcode 17 minutes ago
Looks like things might get interesting real fast for AVXL longs!
AVXL
janice shell janice shell 18 minutes ago
But of course.
janice shell janice shell 19 minutes ago
I'd never even heard of Cedar Rapids. But it looks hilarious.